CoChat
Sign Up
Cited by 237Lipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismLipid metabolism and disorders

The DOI matches its Crossref record; 65 of the 67 references it cites were found in a registry or an index.

Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia.

Open access
Dejager, S, Bruckert, E, Chapman, MJ·1993·Journal of Lipid Research
DOI 10.1016/s0022-2275(20)40756-4
Open this paper in CoChat — free account

Abstract

Patients presenting combined hyperlipidemia (CHL) display an elevated risk of coronary heart disease. The atherogenic lipoprotein particles implicated in this disorder remain ill defined. We determined the qualitative and quantitative characteristics of the density distribution of low density lipoprotein (LDL) particle subspecies in nine subjects defined phenotypically as presenting CHL, and under strict dietary control. Seven CHL patients possessed familial antecedents of premature coronary heart disease; none were E2E2 homozygotes. Five LDL subspecies were isolated by density gradient ultracentrifugation in the density range 1.019-1.063 g/ml. In all patients, the LDL profile was skewed towards the dense subspecies (LDL-4, d 1.039-1.050 g/ml and LDL-5, d 1.050-1.063 g/ml), representing 47% of total LDL mass; by contrast, these subspecies accounted for only 30% of LDL mass in five normolipidemic subjects (P < 0.01). In addition, plasma LDL mass concentrations were some twofold higher in CHL patients as compared to normolipidemic subjects. The % mass of LDL-4 was positively correlated with plasma triglyceride and apoB levels. LDL-2 and LDL-3 in CHL patients were triglyceride-enriched (11.9 and 7.2%, respectively) as compared to the corresponding subspecies in normolipidemic subjects (6.6 and 3.7%, respectively; P < 0.05 in each case). LDL particle size decreased with increase in density in both groups; however, significant differences were found between corresponding LDL subspecies (LDL-1, -3, -4, and -5) in CHL patients and normolipidemic subjects, a finding suggestive of dissimilar molecular organization, despite correspondence in hydrated density. The copper-induced oxidative modification of LDL subspecies was assessed by determination of conjugated diene formation. In both groups, LDL-5 was distinct in exhibiting a marked diminution in oxidative resistance as indicated by a significant reduction (P < 0.01) in mean lag time. The oxidative susceptibility of LDL subspecies in both groups was independent of vitamin E content when expressed as the ratio vitamin E/LDL mass, although dense LDL in CHL patients tended to be deficient in this antioxidant. The diminished oxidative resistance of dense LDL subspecies could not be accounted for by enrichment in polyunsaturated fatty acids in either group. These studies suggest that in consequence of their elevated circulating concentration and diminished oxidative resistance, dense LDL subspecies represent putative atherogenic subspecies in combined hyperlipidemia.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0022-2275(20)40756-4

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 67 references

Research works printed but not linked: 2

  1. Steinberg, 1989, Modifications of low-density lipoprotein that increase its atherogenicity, N. Engl. J. Med., 320, 915
  2. Esterbauer, 1989, Continuous monitoring of in vitro oxidation of human low density lipoprotein, Free Rod. Res. Commun., 6, 67

Cited by

Sorted by citations

See all 237

Related

Metadata

Authors
Dejager, S., Bruckert, E., & Chapman, M.
Affiliations
Inserm (FR)
ORCID
Chapman, MJ
Venue
Journal of Lipid Research
Publisher
Elsevier BV
Published
1993-02
Volume
34
Issue
2
Pages
295-308
ISSN
0022-2275 (ISSN-L)
DOI
10.1016/s0022-2275(20)40756-4
OpenAlex
W2135183362
Cited by
237
References
67
Citations by year
2026: 2 · 2025: 3 · 2024: 3 · 2023: 1 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 2 · 2017: 3 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 2 · 2012: 5
FWCI
24.34
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Lipid Research (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords
mixed dyslipidemia, LDL particle size, LDL oxidation, copper-induced oxidation, conjugated dienes, vitamin E, atherogenic lipoproteins, apolipoprotein B, coronary heart disease risk, dietary management, familial hypercholesterolemia
MeSH terms
Adult, Centrifugation, Density Gradient, Chemistry, Physical, Humans, Hyperlipidemia, Familial Combined, Lipid Peroxides, Lipoproteins, LDL, Male, Middle Aged, Oxidation-Reduction, Particle Size, Vitamin E, Lipoprotein(a), Chemical Phenomena

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review